← Browse by Condition
Medical Condition
primary biliary cholangitis
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3, Phase 2
NCT06447168
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
Enrollment
424 pts
Location
United States, Austr...
Sponsor
Ipsen
NCT05151809
Recruiting
National Database on Primary Biliary Cholangitis
Enrollment
6,000 pts
Location
Italy
Sponsor
University of Milano Bicocca
NCT07282353 Phase 3
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Enrollment
135 pts
Location
China
Sponsor
Cascade Pharmaceuticals, Inc
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argen...
Sponsor
Mirum Pharmaceuticals, Inc.